Eur J Clin Nutr 61:892895 Power RA, Hulver MW, Zhang JY, Dubois J, Marchand RM, Ilkayeva O, Muoio DM, Mynatt RL (2007) Carnitine revisited: potential use as adjunctive treatment in diabetes
Separate-Vial Reconstitution Reconstitution math for 10 mg standalone vials Vial CJC-1295 10 mg BAC water 3.0 mL Concentration 3.33 mg/mL 200 mcg dose 6 units (0.06 mL) Vial Ipamorelin 10 mg BAC water 3.0 mL Concentration 3.33 mg/mL 200 mcg dose 6 units (0.06 mL) This separate-vial reference uses 3.0 mL as the maximum fill for the same vial-capacity constraint
Preclinical studies are needed to elucidate the underlying mechanisms
However, all of the published human studies have used R,S -lipoic acid (racemic mixture)
This raises a theoretical concern: could activating the Wnt pathway to grow hair also increase cancer risk
Exceeding this window risks reduced potency, though the medication typically doesn't become harmful